IT201600105831A1 - Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo - Google Patents

Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo

Info

Publication number
IT201600105831A1
IT201600105831A1 IT102016000105831A IT201600105831A IT201600105831A1 IT 201600105831 A1 IT201600105831 A1 IT 201600105831A1 IT 102016000105831 A IT102016000105831 A IT 102016000105831A IT 201600105831 A IT201600105831 A IT 201600105831A IT 201600105831 A1 IT201600105831 A1 IT 201600105831A1
Authority
IT
Italy
Prior art keywords
regulation
extract
reduction
body weight
composition based
Prior art date
Application number
IT102016000105831A
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Priority to IT102016000105831A priority Critical patent/IT201600105831A1/it
Priority to MA046664A priority patent/MA46664A/fr
Priority to US16/343,329 priority patent/US20190255131A1/en
Priority to PCT/IB2017/056522 priority patent/WO2018073794A1/en
Priority to CN201780064756.4A priority patent/CN110167568A/zh
Priority to EP17801106.0A priority patent/EP3528826A1/en
Publication of IT201600105831A1 publication Critical patent/IT201600105831A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT102016000105831A 2016-10-20 2016-10-20 Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo IT201600105831A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT102016000105831A IT201600105831A1 (it) 2016-10-20 2016-10-20 Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
MA046664A MA46664A (fr) 2016-10-20 2017-10-20 Composition comprenant un extrait d'irvingia gabonensis et souches de bifidobactéries pour réguler et réduire le poids corporel
US16/343,329 US20190255131A1 (en) 2016-10-20 2017-10-20 A composition comprising an extract of irvingia gabonensis and strains of bifidobacteria for regulating and reducing body weight
PCT/IB2017/056522 WO2018073794A1 (en) 2016-10-20 2017-10-20 A composition comprising an extract of irvingia gabonensis and strains of bifidobacteria for regulating and reducing body weight
CN201780064756.4A CN110167568A (zh) 2016-10-20 2017-10-20 基于加蓬野芒果提取物和双歧杆菌菌株的用于调节和减轻体重的组合物
EP17801106.0A EP3528826A1 (en) 2016-10-20 2017-10-20 A composition comprising an extract of irvingia gabonensis and strains of bifidobacteria for regulating and reducing body weight

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000105831A IT201600105831A1 (it) 2016-10-20 2016-10-20 Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo

Publications (1)

Publication Number Publication Date
IT201600105831A1 true IT201600105831A1 (it) 2018-04-20

Family

ID=58159393

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000105831A IT201600105831A1 (it) 2016-10-20 2016-10-20 Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo

Country Status (6)

Country Link
US (1) US20190255131A1 (it)
EP (1) EP3528826A1 (it)
CN (1) CN110167568A (it)
IT (1) IT201600105831A1 (it)
MA (1) MA46664A (it)
WO (1) WO2018073794A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100098792A1 (en) * 2008-10-17 2010-04-22 Gateway Health Alliances, Inc. Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglycerides levels and increase adiponectin levels
US20120244125A1 (en) * 2009-09-30 2012-09-27 Nestec S.A. Bifidobacterium longum atcc baa-999 (bl999) and weight control
US20120301573A1 (en) * 2011-05-29 2012-11-29 Rufina Shatkina Composition and method for suppressing appetite
US20140079676A1 (en) * 2012-09-20 2014-03-20 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100098792A1 (en) * 2008-10-17 2010-04-22 Gateway Health Alliances, Inc. Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglycerides levels and increase adiponectin levels
US20120244125A1 (en) * 2009-09-30 2012-09-27 Nestec S.A. Bifidobacterium longum atcc baa-999 (bl999) and weight control
US20120301573A1 (en) * 2011-05-29 2012-11-29 Rufina Shatkina Composition and method for suppressing appetite
US20140079676A1 (en) * 2012-09-20 2014-03-20 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Eating Yogurt Is Not Enough: Take Probiotics The Right Way", 14 February 2016 (2016-02-14), XP002770694, Retrieved from the Internet <URL:http://www.nutritionw.com/eating-yogurt-is-not-enough-take-probiotics-the-right-way/> [retrieved on 20170531] *
ANONYMOUS: "Probulin - TrimSynergy Probiotic 20 Billion CFU - 60 Capsules", 29 September 2015 (2015-09-29), XP002770693, Retrieved from the Internet <URL:https://www.shopyourway.com/probulin-trimsynergy/455016222> [retrieved on 20170531] *
ANONYMOUS: "Veda Slim Protein Shake", 10 September 2013 (2013-09-10), XP002770692, Retrieved from the Internet <URL:http://mahimacenter.com/product/veda-slim-protein-shake/> [retrieved on 20170531] *
NGONDI JUDITH L ET AL: "IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation", LIPIDS IN HEALTH AND DISEASE, BIOMED CENTRAL, LONDON, GB, vol. 8, no. 1, 2 March 2009 (2009-03-02), pages 7, XP021050206, ISSN: 1476-511X, DOI: 10.1186/1476-511X-8-7 *

Also Published As

Publication number Publication date
US20190255131A1 (en) 2019-08-22
EP3528826A1 (en) 2019-08-28
MA46664A (fr) 2019-08-28
WO2018073794A1 (en) 2018-04-26
CN110167568A (zh) 2019-08-23

Similar Documents

Publication Publication Date Title
IL254977B (en) Biological conjugates and their uses
IL263759B (en) A situation-aware personal assistant
IL253123B (en) Preparations for administration through the skin and their uses
ZA201901032B (en) Immunogenic/therapeutic glycan compositions and uses thereof
IL263574A (en) calr and jak2 preparations
ZA201900275B (en) Oral gastroretentive formulations and uses thereof
MA54716A (fr) Réduction de la viscosité de formulations pharmaceutiques
MA46867A (fr) Formulations pharmaceutiques
IL273339A (en) Griseofulbin compound and its medical use
IL273839A (en) Benzimidazole derivatives and their uses
ZA201807730B (en) An oral care composition
SG11201911750RA (en) Low-dose brimonidine combinations and uses thereof
IL248925A0 (en) Curcumin-peptide conjugates and their formulations
IL281425A (en) Nanoparticle formulations
IL248773B (en) History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them
HUE052751T2 (hu) Natív OMV-antigén konjugátumok és alkalmazásuk
SG10202112759SA (en) Antimalarial compositions and uses thereof
IL273644A (en) Formulations of bendamustine for oral administration
ZA201902804B (en) Personal care composition
EP3441075A4 (en) ORAL COMPOSITION OF ESSENTIAL OILS AND USE THEREOF
IT201600105831A1 (it) Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
GB201911959D0 (en) Immunogenic compositions and uses therefor
IL264898A (en) Formulations of cysteamine and its derivatives
ZA201903341B (en) Pharmaceutical compositions and uses thereof
GB201619946D0 (en) Conjugated immunogenic derivatives and use thereof